October 07, 2022
2 min watch
Save
VIDEO: Presbyopes treated with Vuity show increase in near, intermediate vision
CHICAGO — In this Healio Video Perspective from the AAO meeting, Beeran B. Meghpara, MD, discusses 30-day data from the GEMINI 1 and GEMINI 2 studies.
The studies examined visual acuity responses to Vuity (pilocarpine HCl ophthalmic solution 1.25%, Allergan) in patients with presbyopia.
“Data showed that there was a significant increase in near and intermediate vision without compromising distance vision,” Meghpara said.
Published by:
Sources/Disclosures
Collapse
Source:
Meghpara BB, et al. Efficacy of pilocarpine HCl ophthalmic solution 1.25% in emmetropes and nonemmetropes in the 30-day GEMINI 1 and GEMINI 2 studies. Presented at: American Academy of Ophthalmology meeting; Sept. 30-Oct. 3, 2022; Chicago.
Disclosures:
Meghpara reports being a consultant and speaker for AbbVie/Allergan.
Read more about